Drugs / Ad-PfCA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01843491 | Jun 2013 → Jun 2014 | malaria | U.S. Army Medical Research and Development Command | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ad-PfCA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01843491 ↗ |
| Modality | Vaccine | “This is an open label Phase 1 study of the Ad-PfCA vaccine designed to” NCT01843491 ↗ |
| Route | Intramuscular | “by intramuscular injection” NCT01843491 ↗ |